APA (7th ed.) Citation

Wang, J., Xu, R., Li, J., Bai, Y., Liu, T., Jiao, S., . . . Shen, L. (2016). Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 19(1), 234-244. https://doi.org/10.1007/s10120-015-0457-4

Chicago Style (17th ed.) Citation

Wang, Jinwan, et al. "Randomized Multicenter Phase III Study of a Modified Docetaxel and Cisplatin Plus Fluorouracil Regimen Compared with Cisplatin and Fluorouracil as First-line Therapy for Advanced or Locally Recurrent Gastric Cancer." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 19, no. 1 (2016): 234-244. https://doi.org/10.1007/s10120-015-0457-4.

MLA (9th ed.) Citation

Wang, Jinwan, et al. "Randomized Multicenter Phase III Study of a Modified Docetaxel and Cisplatin Plus Fluorouracil Regimen Compared with Cisplatin and Fluorouracil as First-line Therapy for Advanced or Locally Recurrent Gastric Cancer." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 19, no. 1, 2016, pp. 234-244, https://doi.org/10.1007/s10120-015-0457-4.